NTRA
Natera, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$399.42
+1.52%0
Insider buys (3m)
123
Insider sells (3m)
-$101.4M
Net value (3m)
+53.6%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Oct 16, 2026 | Rabinowitz Matthew · director, officer: EXECUTIVE CHAIRMAN | Sale | 800 | $393 |
| Oct 16, 2026 | Rabinowitz Matthew · director, officer: EXECUTIVE CHAIRMAN | Sale | 2,671 | $400 |
| Oct 16, 2026 | Rabinowitz Matthew · director, officer: EXECUTIVE CHAIRMAN | Sale | 793 | $399 |
| Oct 16, 2026 | Rabinowitz Matthew · director, officer: EXECUTIVE CHAIRMAN | Sale | 300 | $392 |
| Oct 16, 2026 | Rabinowitz Matthew · director, officer: EXECUTIVE CHAIRMAN | Sale | 2,000 | $408 |
| Oct 16, 2026 | Rabinowitz Matthew · director, officer: EXECUTIVE CHAIRMAN | M-Exempt | 50,000 | $10 |
| Oct 16, 2026 | Rabinowitz Matthew · director, officer: EXECUTIVE CHAIRMAN | Sale | 3,800 | $407 |
| Oct 16, 2026 | Rabinowitz Matthew · director, officer: EXECUTIVE CHAIRMAN | Sale | 5,974 | $401 |
| Oct 16, 2026 | Rabinowitz Matthew · director, officer: EXECUTIVE CHAIRMAN | Sale | 1,400 | $407 |
| Oct 16, 2026 | Rabinowitz Matthew · director, officer: EXECUTIVE CHAIRMAN | Sale | 1,900 | $396 |
| Oct 16, 2026 | Rabinowitz Matthew · director, officer: EXECUTIVE CHAIRMAN | Sale | 10,321 | $405 |
| Oct 16, 2026 | Rabinowitz Matthew · director, officer: EXECUTIVE CHAIRMAN | Sale | 1,100 | $397 |
| Oct 16, 2026 | Rabinowitz Matthew · director, officer: EXECUTIVE CHAIRMAN | Sale | 3,858 | $403 |
| Oct 16, 2026 | Rabinowitz Matthew · director, officer: EXECUTIVE CHAIRMAN | Sale | 600 | $390 |
| Oct 16, 2026 | Rabinowitz Matthew · director, officer: EXECUTIVE CHAIRMAN | Sale | 714 | $390 |
| Oct 16, 2026 | Rabinowitz Matthew · director, officer: EXECUTIVE CHAIRMAN | Sale | 286 | $388 |
| Oct 16, 2026 | Rabinowitz Matthew · director, officer: EXECUTIVE CHAIRMAN | Sale | 6,309 | $402 |
| Oct 16, 2026 | Rabinowitz Matthew · director, officer: EXECUTIVE CHAIRMAN | Sale | 6,274 | $405 |
| Oct 2, 2026 | Moshkevich Solomon · officer: PRESIDENT, CLINICALDIAGNOSTICS | Sale | 954 | $413 |
| Oct 2, 2026 | Moshkevich Solomon · officer: PRESIDENT, CLINICALDIAGNOSTICS | Sale | 200 | $412 |
| Oct 2, 2026 | Chapman Steven Leonard · director, officer: CEO AND PRESIDENT | Sale | 1,273 | $413 |
| Oct 2, 2026 | Moshkevich Solomon · officer: PRESIDENT, CLINICALDIAGNOSTICS | Sale | 1,846 | $415 |
| Sep 25, 2026 | Sheena Jonathan · director, other: CO-FOUNDER | Sale | 2,300 | $387 |
| Sep 25, 2026 | Sheena Jonathan · director, other: CO-FOUNDER | Sale | 1,293 | $389 |
| Sep 25, 2026 | Sheena Jonathan · director, other: CO-FOUNDER | Sale | 2,846 | $388 |
| Sep 25, 2026 | Sheena Jonathan · director, other: CO-FOUNDER | Sale | 220 | $391 |
| Sep 25, 2026 | Sheena Jonathan · director, other: CO-FOUNDER | Sale | 390 | $385 |
| Sep 25, 2026 | Sheena Jonathan · director, other: CO-FOUNDER | Sale | 2,320 | $390 |
| Sep 25, 2026 | Sheena Jonathan · director, other: CO-FOUNDER | Sale | 2,734 | $388 |
| Sep 25, 2026 | Sheena Jonathan · director, other: CO-FOUNDER | Sale | 400 | $385 |
Institutional positioning
13F filings over the trailing two quarters
New 274Increased 663Reduced 523Sold out 78
| Filer | Action | Shares | Filed |
|---|---|---|---|
| JPMORGAN CHASE & CO | Increased | 13,386,667 | May 13, 2026 |
| JPMORGAN CHASE & CO | Reduced | 12,865,346 | Aug 12, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | Increased | 12,184,876 | May 15, 2026 |
| BlackRock, Inc. | Increased | 10,914,608 | Aug 7, 2026 |
| BLACKROCK, INC. | Reduced | 10,677,338 | May 13, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | Reduced | 9,021,895 | Aug 14, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 6,228,216 | Aug 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 6,008,496 | May 15, 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | Increased | 5,782,640 | Aug 13, 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | New Position | 5,644,695 | May 8, 2026 |
| FMR LLC | Increased | 5,451,396 | Aug 13, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | Reduced | 4,768,593 | May 15, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | Reduced | 4,040,738 | Aug 14, 2026 |
| STATE STREET CORP | Increased | 3,655,618 | Sep 22, 2026 |
| STATE STREET CORP | Increased | 3,417,472 | May 15, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Oct 16, 2026